HANGZHOU and SHANGHAI, China, June 1, 2026 /PRNewswire/ -- Minghui Pharmaceutical ("Minghui"), a late-stage clinical biopharmaceutical company focused on developing innovative therapies for oncology and autoimmune diseases, today announced updated clinical data from its Phase I/II study evaluating MHB088C (QLC5508) in heavily treated patients with metastatic castration-resistant prostate cancer (mCRPC). The results were presented in a poster session at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting.
Poster title: | Safety and efficacy of QLC5508 (MHB088C) in heavily-treated patients with metastatic castration-resistant prostate cancer: Updated data from a phase 1/2 trial |
Poster session: | Genitourinary Cancer—Prostate, Testicular, and Penile |
kAm%96 FA52E65 7:?5:?8D 56>@?DEC2E65 6?4@FC28:?8 2?E:\EF>@C 24E:G:EJ 2?5 5FC23=6 5:D62D6 4@?EC@= :? 962G:=J AC6EC62E65 >r#!r A2E:6?ED[ :?4=F5:?8 A2E:6?ED AC6G:@FD=J EC62E65 H:E9 2?5C@86? C646AE@C A2E9H2J :?9:3:E@CD Wp#!xDX 2?5 E2I2?6\32D65 496>@E96C2AJ]k^Am
kAmpD @7 E96 52E2 4FE@77 52E6 @7 }@G6>36C b_[ a_ad[ dh A2E:6?ED 925 366? 6?C@==65 :? E96 DEF5J] %96 A2E:6?E A@AF=2E:@? C6AC6D6?E65 2 962G:=J AC6EC62E65 D6EE:?8ik^Am
kF= EJA6lQ5:D4Qmk=:mfc]eT C646:G65 E9C66 @C >@C6 AC:@C =:?6D @7 E96C2AJk^=:mk=:mgc]fT 925 AC:@C E2I2?6D 6IA@DFC6k^=:mk=:mag]gT C646:G65 E9C66 @C >@C6 AC:@C =:?6D @7 D64@?5\86?6C2E:@? p#!xDk^=:mk=:m`e]hT 925 C646:G65 EH@ @C >@C6 AC:@C =:?6D @7 E2I2?6Dk^=:mk^F=m
kAmkDEC@?8mr=:?:42= p4E:G:EJk^DEC@?8mk^Am
kF= EJA6lQ5:D4Qmk=:m|wq_ggr 56>@?DEC2E65 5FC23=6 2?E:\EF>@C 24E:G:EJ]k^=:mk=:m%96 >65:2? C!u$ H2D ?@E C624965 WhdT 4@?7:56?46 :?E6CG2= ,rx.[ `b]kDA2? :5lQDA2?w89=Ed`2`Qm`k^DA2?m\?@E 6G2=F23=6 ,}t.X[ H:E9 2 `a\>@?E9 C!u$ C2E6 @7 f`]fT WhdT rx[ da]kDA2? :5lQDA2?w89=E2b2aQmek^DA2?mT\gc]kDA2? :5lQDA2?w89=E72gfQmbk^DA2?mTX]k^=:mk=:mp>@?8 kDA2? :5lQDA2?w89=E42_dQmc_k^DA2?m A2E:6?ED EC62E65 2E E96 a]_ >8^<8 "a( 5@D6[ >65:2? C!u$ H2D 2=D@ ?@E C624965 WhdT rx[ `b]kDA2? :5lQDA2?w89=E5geaQm`k^DA2?m\}tX[ H:E9 2 `a\>@?E9 C!u$ C2E6 @7 fg]eT WhdT rx[ d_]kDA2? :5lQDA2?w89=Eg3daQmfk^DA2?mT\h`]kDA2? :5lQDA2?w89=E64bgQmgk^DA2?mTX]k^=:mk^F=m
kAmkDEC@?8m$276EJ !C@7:=6k^DEC@?8mk^Am
kF= EJA6lQ5:D4Qmk=:m|wq_ggr 56>@?DEC2E65 2 >2?28623=6 D276EJ AC@7:=6[ 4@?D:DE6?E H:E9 AC:@C 4=:?:42= 52E2k^=:mk=:m|@DE 4@>>@? vC256 ≥b EC62E>6?E\6>6C86?E 25G6CD6 6G6?ED W%tptDXikF= EJA6lQ4:C4=6Qmk=:m}6FEC@A9:= 4@F?E 564C62D65 Wad]cTXk^=:mk=:mp?6>:2 Wab]fTXk^=:mk=:m(9:E6 3=@@5 46== 4@F?E 564C62D65 Wa_]bTXk^=:mk^F=mk^=:mk^F=m
kAmQ%96D6 FA52E65 52E2 AC6D6?E65 2E p$r~ 7FCE96C C6:?7@C46 E96 A@E6?E:2= @7 |wq_ggr 2D 2 5:776C6?E:2E65 E96C2A6FE:4 @AE:@? 7@C A2E:6?ED H:E9 >6E2DE2E:4 42DEC2E:@?\C6D:DE2?E AC@DE2E6 42?46C[ A2CE:4F=2C=J E9@D6 H:E9 =:>:E65 EC62E>6?E 2=E6C?2E:G6D 27E6C >F=E:A=6 AC:@C E96C2A:6D[Q D2:5 vF@B:?8 r2@[ !9]s][ r9:67 tI64FE:G6 ~77:46C @7 |:?89F: !92C>246FE:42=] Q(6 2C6 6?4@FC2865 3J E96 5FC23=6 4=:?:42= 36?67:E @3D6CG65 H:E9 |wq_ggr[ :?4=F5:?8 AC@=@?865 5:D62D6 4@?EC@= :? E9:D 962G:=J AC6EC62E65 A2E:6?E A@AF=2E:@?[ E@86E96C H:E9 :ED >2?28623=6 D276EJ AC@7:=6] %96D6 7:?5:?8D 7FCE96C DEC6?8E96? @FC 4@?7:56?46 :? E96 A@E6?E:2= @7 |wq_ggr E@ 255C6DD D:8?:7:42?E F?>6E ?665D 7@C A2E:6?ED H:E9 >6E2DE2E:4 42DEC2E:@?\C6D:DE2?E AC@DE2E6 42?46C[ 2?5 H6 =@@< 7@CH2C5 E@ 25G2?4:?8 E96 AC@8C2> E9C@F89 :ED ?6IE DE286 @7 56G6=@A>6?E]Qk^Am
kAmkDEC@?8mp3@FE |wq_ggrk^DEC@?8mk^Am
kAm|wq_ggr :D 2? :?G6DE:82E:@?2= qf\wb\E2C86E65 2?E:3@5J\5CF8 4@?;F82E6 WpsrX 56G6=@A65 FD:?8 |:?89F:VD AC@AC:6E2CJ $FA6C%@A@:â„¢ A=2E7@C>]k^Am
kAm&?56C 2? 6I4=FD:G6 =:46?D:?8 2?5 4@==23@C2E:@? 28C66>6?E[ ":=F !92C>246FE:42= 9@=5D C:89ED 7@C E96 56G6=@A>6?E[ >2?F724EFC:?8[ 2?5 4@>>6C4:2=:K2E:@? @7 |wq_ggr :? vC62E6C r9:?2] |:?89F: C6E2:?D r9:?2\32D65 4@>3:?2E:@? DEF5J C:89ED H:E9 |wq_bhp 2?5 8=@32= C:89ED @FED:56 vC62E6C r9:?2]k^Am
kAmx? vC62E6C r9:?2[ ":=F :D 25G2?4:?8 E96 4=:?:42= 56G6=@A>6?E @7 |wq_ggr 24C@DD >F=E:A=6 :?5:42E:@?D] %96 AC@8C2> 92D C646:G65 E9C66 qC62<E9C@F89 %96C2AJ s6D:8?2E:@?D 2?5 :D 4FCC6?E=J 36:?8 6G2=F2E65 :? EH@ !92D6 b DEF5:6D :? D64@?5\=:?6 D>2== 46== =F?8 42?46C W$r{rX 2?5 D64@?5\=:?6 6D@A92862= DBF2>@FD 46== 42C4:?@>2 Wt$rrX]k^Am
kAm|:?89F: :D 25G2?4:?8 255:E:@?2= 4=:?:42= 56G6=@A>6?E DEC2E68:6D 7@C |wq_ggr] ~?8@:?8 DEF5:6D :? r9:?2 :?4=F56 2 !92D6 x^xx EC:2= 6G2=F2E:?8 |wq_ggr :? 4@>3:?2E:@? H:E9 |wq_bhp[ |:?89F:VD :?G6DE:82E:@?2= !s\`^'tvu 3:DA64:7:4 2?E:3@5J[ :? A2E:6?ED H:E9 25G2?465 D@=:5 EF>@CD[ :?4=F5:?8 7:CDE\=:?6 $r{r 6IA2?D:@? 4@9@CED]k^Am
kAmkDEC@?8mp3@FE |:?89F: !92C>246FE:42=k^DEC@?8mk^Am
kAm|:?89F: !92C>246FE:42= :D 2 =2E6\DE286 4=:?:42= 3:@A92C>246FE:42= 4@>A2?J 7@4FD65 @? 56G6=@A:?8 :??@G2E:G6 >65:4:?6D E@ 255C6DD F?>6E ?665D :? @?4@=@8J 2?5 :>>F?@=@8J] {6G6C28:?8 566A D4:6?E:7:4 6IA6CE:D6 2?5 AC@AC:6E2CJ E649?@=@8J A=2E7@C>D[ E96 4@>A2?J 92D 3F:=E 2 C@3FDE 2?5 5:776C6?E:2E65 A:A6=:?6 @7 ?@G6= E96C2A:6D]k^Am
kAm|:?89F:VD =625 2DD6ED :?4=F56 2? :??@G2E:G6 E@A:42= ypz :?9:3:E@C 4FCC6?E=J F?56C }sp C6G:6H :? r9:?2j 2 DF34FE2?6@FD xvu\`# 2?E:3@5J :? !92D6 xxx EC:2=D 7@C E9JC@:5 6J6 5:D62D6j 2 ?@G6= !s\`^'tvu 3:DA64:7:4 2?E:3@5J :? !92D6 a EC:2=D[ 36:?8 6G2=F2E65 :? 4@>3:?2E:@? H:E9 2 %#~!a psrj 2?5 2 qf\wb psr :? !92D6 b EC:2= 7@C a{ $r{r —3@E9 psrD H:E9 DEC@?8 36DE\:?\4=2DD A@E6?E:2=]k^Am
kAmkDEC@?8mu@CH2C5\{@@<:?8 $E2E6>6?EDk^DEC@?8mk^Am
kAm%9:D AC6DD C6=62D6 4@?E2:?D 7@CH2C5\=@@<:?8 DE2E6>6?ED C682C5:?8 |wq_ggr 2?5 :ED 4=:?:42= 56G6=@A>6?E A=2?D[ :?4=F5:?8 A@E6?E:2= E96C2A6FE:4 36?67:ED[ @?8@:?8 2?5 A=2??65 4=:?:42= DEF5:6D[ C68F=2E@CJ 6IA64E2E:@?D[ 2?5 7FEFC6 56G6=@A>6?E 24E:G:E:6D] %96D6 DE2E6>6?ED 2C6 32D65 @? E96 r@>A2?JVD 4FCC6?E 6IA64E2E:@?D 2?5 2C6 DF3;64E E@ G2C:@FD C:D<D 2?5 F?46CE2:?E:6D E92E 4@F=5 42FD6 24EF2= C6DF=ED E@ 5:776C >2E6C:2==J 7C@> E9@D6 6IAC6DD65 @C :>A=:65 96C6:?[ :?4=F5:?8 C:D<D C6=2E65 E@ 4=:?:42= 56G6=@A>6?E[ C68F=2E@CJ C6G:6H[ >2?F724EFC:?8[ :?E6==64EF2= AC@A6CEJ AC@E64E:@?[ 2?5 @E96C 724E@CD] %96 r@>A2?J F?56CE2<6D ?@ @3=:82E:@? E@ FA52E6 2?J 7@CH2C5\=@@<:?8 DE2E6>6?ED 6I46AE 2D C6BF:C65 3J 2AA=:423=6 =2HD 2?5 C68F=2E:@?D]k^Am
kA :5lQ!&#{Qmk:>8 E:E=6lQr:D:@?Q H:5E9lQ`aQ 96:89ElQ`aQ 2=ElQr:D:@?Q DC4lQ9EEADi^^6586]AC?6HDH:C6]4@>^4^:>8^72G:4@?]A?8nD?lr}fa`c`U2>AjD5la_ae\_e\_`Q ^m ':6H @C:8:?2= 4@?E6?Eik2 :5lQ!#}&#{Q C6=lQ?@7@==@HQ 9C67lQ9EEADi^^HHH]AC?6HDH:C6]4@>^?6HD\C6=62D6D^>:?89F:\A92C>246FE:42=\2?5\B:=F\A92C>246FE:42=\4@\2??@F?46D\FA52E65\4=:?:42=\52E2\@7\>93_gg4\B=4dd_g\7C@>\A92D6\:::\DEF5J\:?\962G:=J\AC6EC62E65\>4CA4\A2E:6?ED\2E\a_ae\2D4@\2??F2=\>66E:?8\b_afgeeha]9E>=Q E2C86ElQ03=2?<Qm9EEADi^^HHH]AC?6HDH:C6]4@>^?6HD\C6=62D6D^>:?89F:\A92C>246FE:42=\2?5\B:=F\A92C>246FE:42=\4@\2??@F?46D\FA52E65\4=:?:42=\52E2\@7\>93_gg4\B=4dd_g\7C@>\A92D6\:::\DEF5J\:?\962G:=J\AC6EC62E65\>4CA4\A2E:6?ED\2E\a_ae\2D4@\2??F2=\>66E:?8\b_afgeeha]9E>=k^2mk^Am
kAm$~&#rt |:?89F: !92C>246FE:42=k^Am
kAmk:>8 2=ElQQ DC4lQ9EEADi^^CE]AC?6HDH:C6]4@>^CE]8:7n}6HDxE6>x5lr}fa`c`U2>Aj%C2?D>:DD:@?0x5la_ae_e_`____!#0}t($0&$!#00000r}fa`c`U2>Ajs2E6x5la_ae_e_`Q DEJ=6lQ3@C56Ci_AIj H:5E9i`AIj 96:89Ei`AIjQ ^mk^Am
